SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1384>>One key issue is the efficiency of the sales force that ICOS is buildingIcebrg-2/26/2005
1383<i>ICOS will make more money from Cialis later by virtue of incurring lossBiomaven-2/25/2005
1382<I>Since mass is now said in the vernacular, expectations of formal usage zeta1961-2/20/2005
1381If you was a member of SI, we could discuss this to longer length. In perpetuitJohn Metcalf-2/19/2005
1380Your style is not the one used by many leading publications, e.g. WSJ, NYT, The DewDiligence_on_SI-2/19/2005
1379The grammatical issue concerns when to use the indicative ("was") vs. software salesperson-2/18/2005
1378<i>>>What part of "If" don't you understand? <<&DewDiligence_on_SI-2/18/2005
1377What part of "If" don't you understand?rkrw-2/18/2005
1376<i> If you think the icos deal was equivalent to nbix's then…</i>DewDiligence_on_SI-2/18/2005
1375>That’s utter nonsense< Wish I had said if differently. ICOS would be mafred hayes-2/18/2005
1374<<That’s utter nonsense.>> There's been several products recentrkrw-2/18/2005
1373<i>>>ICOS is not profitable because of costs associated with partnerDewDiligence_on_SI-2/18/2005
1372>does not change the main theme of the article< It certainly does. ICOS fred hayes-2/18/2005
1371<i>>>One big mistake in the article is that nbix/pfe deal isn't DewDiligence_on_SI-2/18/2005
1370One big mistake in the article is that nbix/pfe deal isn't a profit share, brkrw-2/18/2005
1369One big difference between NBIX and ICOS is that the latter has almost nothing iIcebrg-2/18/2005
1368Sleeping on Neurocrine's Shares By Karl Thiel (TMF BreakerThiel) February 1sim1-2/18/2005
1367Neurocrine Reports Positive Phase III Efficacy and Safety Results With Indiplon mopgcw-2/17/2005
1366Melanocortin Receptor Antagonist Melanocortin receptors are proteins on tscaram(o)uche-2/16/2005
1365Our Product Pipeline The following table summarizes our most advanced proscaram(o)uche-2/16/2005
1364<he used phrases like “ did nothing wrong - - would do the same things over akenhott-2/12/2005
1363i listened to the conference call primarily to see how the filing misadventure wsoftware salesperson-2/12/2005
1362Sold my puts today and bought a couple of shares. Not calls because I may have kenhott-2/11/2005
1361Neurocrine Biosciences "underweight," target price reduced Friday, FeIcebrg-2/11/2005
1360SSB: HOLD (2) Speculative mopgcw-2/11/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News